We are proud to announce that Moehs has taken one step further on the nitrosamines project by publishing an article in the scientific Journal of Separation Science. This is a very important step in the race to have better control of the nitrosamine drug substance-related impurities, NDSRIs in the APIs. At Moehs we have developed …
We announce the appointment of Mr. Javier del Rio as its new CEO replacing Mr. Francisco Escribano after a long career within Moehs. Mr. del Rio is a pharmacist with extensive experience in the pharmaceutical industry, having held various leadership positions in companies of the sector. His background and knowledge will be key to lead …
We end this special week, full of Christmas festivities, with our last video commemorating Moehs’ 60th anniversary. Thank you all for making it possible!
We thank our entire team of professionals for your involvement in the Moehs Group’s 60th anniversary tribute. Thank you for your words, we love to see how we continue growing together!
At Moehs Group we continue celebrating our 60th anniversary, among all departments. Thank you all for your professionalism!
There is no better way to say goodbye to the year than with this beautiful video commemorating our 60th anniversary at Moehs Group. We are proud of our work, our professionals and the relevant results we bring to the pharmaceutical industry.
At Moehs Group, we remain committed to innovation as a fundamental value to continue growing. For this reason, over the last two years, we have invested more than 20 million euros in order to continue being a reference in the manufacture of active pharmaceutical ingredients. More details about the investments in the video:
At Moehs we adapt to all social and environmental circumstances. For this reason, we have revolutionized our processes by adapting a new digitalization system, in particular quality control and documentation. Our data integrity is now technologically excellent. Thank you Marqués and ShareMe for your professionalism and ease of adaptation to Moehs.
At Moehs we continue innovating with the latest technologies, robotising our manufacturing processes. More safety, traceability and efficiency. That is why we are leaders in the production of active ingredients for the pharmaceutical sector.
At Moehs we continue innovating to offer the best service to our customers. Recently, we have increased the production capacity of our Moehs BCN site with new reactors without stopping production at any time, which has continued at full capacity. Our thanks to the engineering, maintenance and management team.
